Dapsone in the treatment of persistent erythema multiforme

J Drugs Dermatol. 2006 Apr;5(4):375-6.

Abstract

Erythema multiforme (EM) is usually an acute and self-limited inflammatory reaction of the skin and mucous membranes. Attacks may be sporadic or recurrent, and generally last for 1 to 3 weeks. Rarely, an episode of EM may fail to abate. This continuous and uninterrupted occurrence of typical and atypical lesions is known as persistent EM. We present a case responsive to dapsone.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Dapsone / administration & dosage
  • Dapsone / therapeutic use*
  • Erythema Multiforme / drug therapy*
  • Female
  • Humans
  • Middle Aged
  • Recurrence
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Dapsone